tiprankstipranks
TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
US Market
Holding RNAZ?
Track your performance easily

TransCode Therapeutics (RNAZ) Financial Statements

295 Followers

TransCode Therapeutics Financial Overview

TransCode Therapeutics's market cap is currently ―. The company's EPS TTM is $-265.834; its P/E ratio is ―; TransCode Therapeutics is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is $-3.21. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -2.31M$ -5.19M$ -3.34M$ -5.30M$ -4.33M
EBITDA$ -2.18M$ -5.04M$ -3.20M$ -5.16M$ -4.20M
Net Income Common Stockholders$ -2.32M$ -5.19M$ -3.33M$ -5.30M$ -4.34M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.90M$ 3.40M$ 4.90M$ 7.50M$ 3.60M
Total Assets$ 3.94M$ 4.82M$ 7.29M$ 10.23M$ 5.88M
Total Debt$ ―$ ―$ ―$ 594.69K$ 663.29K
Net Debt$ ―$ ―$ ―$ -6.91M$ -2.94M
Total Liabilities$ 2.28M$ 3.50M$ 2.71M$ 5.79M$ 3.79M
Stockholders Equity$ 1.65M$ 1.32M$ 4.58M$ 4.44M$ 2.09M
Cash Flow-
Free Cash Flow$ -3.91M$ -2.40M$ -3.90M-$ -4.41M
Operating Cash Flow$ -3.90M$ -2.40M$ -3.90M$ -3.51M$ -4.39M
Investing Cash Flow$ -12.87K$ -4.55K$ -3.84K$ -4.61K$ -18.11K
Financing Cash Flow$ 2.45M$ 785.20K$ 6.09M$ 7.39M$ 6.36M
Currency in USD

TransCode Therapeutics Earnings and Revenue History

TransCode Therapeutics Debt to Assets

TransCode Therapeutics Cash Flow

TransCode Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis